Darunavir Tablets
Developed to target human immunodeficiency virus infection to support immune system health.
- Category
- HIV Management
- Active ingredient
- Darunavir
- Supply
- Rx
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 600 · 800mg
Darunavir Tablets details
- Condition
- HIV Infection
- Alternative names
- Prezista
- Therapeutic class
- HIV Protease Inhibitor
- Pharmacological class
- Protease Inhibitor
- Contraindications
- hypersensitivity to darunavir; severe hepatic impairment
- Precautions and warnings
- monitor liver enzymes; risk of rash; follow the prescribed regimen
- Minor side effects
- diarrhoea; nausea; headache
- Moderate side effects
- rash; vomiting; abdominal pain
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- Janssen
- Onset Time
- varies per patient
- Duration
- 24 hours
- Storage instructions
- Store below 30°C. Protect from moisture.
- Drug interactions
- st. john's wort; atorvastatin; clopidogrel
Serious side effects
stevens-johnson syndrome, requires immediate medical attention; hepatotoxicity, requires immediate medical attention
Patient summary
developed to target human immunodeficiency virus infection to support immune system health.
Mechanism of action
Darunavir acts as an HIV protease inhibitor, preventing the virus from replicating by blocking the protease enzyme that breaks down precursor proteins in immature HIV cells.
Pregnancy and breastfeeding
Pregnancy: should be used during pregnancy only if the potential benefit justifies the potential risk. Breastfeeding: not recommended for HIV-positive mothers.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Darunavir Tablets
Darunavir Tablets contain the active ingredient darunavir, which is used to manage HIV infection. This medication is also available under the brand name Prezista. It is supplied as a tablet in 600mg and 800mg strengths. Janssen developed this treatment to support the health of those living with the condition.
Darunavir Tablets availability in Asia
Darunavir Tablets are registered across 14 markets, including Malaysia, the Philippines and Indonesia, with availability also in Taiwan, South Korea and Japan. Generic versions of darunavir, much of which is produced in India, provide a more accessible option for individuals living far from a well stocked local pharmacy. This medication is best used under the ongoing care of a doctor.